Phase Ib study of eltrombopag and azacitidine in patients with high-risk myelodysplastic syndromes and related disorders (the ELASTIC study). (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjh.18389
PubMed Identifier: 35918828
Publication URI: http://europepmc.org/abstract/MED/35918828
Type: Journal Article/Review
Volume: 199
Parent Publication: British journal of haematology
Issue: 2
ISSN: 0007-1048